EQ Inc
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 44
- Market Cap
- $36.8M
- Website
- http://www.equilliumbio.com
- Introduction
EQ Inc is a provider of digital marketing services. It operates in a single segment, which is to provide real-time technology and advanced analytics to improve performance for web, mobile, social, and video advertising initiatives and focuses on targeted advertising and incorporates advertising technologies, data analytics, and programmatic media buying capabilities into a single segment. EQ's geographical segments are Canada and the United States, of which the vast majority of its revenue comes from Canada. It generates the highest revenue from Advertising Services, followed by Data sales, which includes fixed CPM data and licenses.
Itolizumab Shows Promising Results in Phase 2 Ulcerative Colitis Trial, Matching Adalimumab Efficacy
Itolizumab demonstrated a 23.3% clinical remission rate in moderate to severe ulcerative colitis patients after 12 weeks, comparable to adalimumab's 20.0% and superior to placebo's 10.0%.
Vivtex and Equillium Collaborate on Oral Biologic for GI Inflammation
Vivtex and Equillium have entered a research agreement to develop an oral formulation of EQ302, a bispecific peptide therapy targeting IL-15 and IL-21.